Hemera Biosciences

OverviewSuggest Edit

Hemera Biosciences is a company that uses gene therapy as a one-time treatment in patients with age-related macular degeneration (AMD). It develops HMR59, a drug that is injected in the eye, increasing the ability of retina cells to make a soluble form of the protective protein CD59.
TypePrivate
Founded2010
HQWaltham, MA, US
Websitehemerabiosciences.com

Locations

Hemera Biosciences is headquartered in
Waltham, United States

Location Map

Latest Updates

Employees (est.) (Sept 2021)2
Cybersecurity ratingBMore

Hemera Biosciences Office Locations

Hemera Biosciences has an office in Waltham
Waltham, MA, US (HQ)
800 South St #600
Show all (1)

Hemera Biosciences Financials and Metrics

Summary Metrics

Founding Date

2010

Hemera Biosciences total Funding

$1.3 m

Hemera Biosciences latest funding size

$1.3 m

Time since last funding

8 years ago
Hemera Biosciences's latest funding round in April 2013 was reported to be $1.3 m. In total, Hemera Biosciences has raised $1.3 m
Show all financial metrics

Hemera Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Hemera Biosciences Online and Social Media Presence

Embed Graph

Hemera Biosciences Frequently Asked Questions

  • When was Hemera Biosciences founded?

    Hemera Biosciences was founded in 2010.

  • How many employees does Hemera Biosciences have?

    Hemera Biosciences has 2 employees.

  • Who are Hemera Biosciences competitors?

    Competitors of Hemera Biosciences include RD-Biotech, Rocket Pharmaceuticals and AnGes.

  • Where is Hemera Biosciences headquarters?

    Hemera Biosciences headquarters is located at 800 South St #600, Waltham.

  • Where are Hemera Biosciences offices?

    Hemera Biosciences has an office in Waltham.

  • How many offices does Hemera Biosciences have?

    Hemera Biosciences has 1 office.